ストックスクリーナーアプリを入手
0.6651
5.91%
0.0371
アフターアワーズ：
.66
-0.0051
-0.77%
前日終値:
$0.628
開ける：
$0.6
24時間の取引高:
2.10M
Relative Volume:
0.43
時価総額：
$20.09M
収益：
-
当期純損益:
$-29.77M
株価収益率:
-0.0435
EPS:
-15.2954
ネットキャッシュフロー:
$-24.23M
1週間 パフォーマンス:
+17.30%
1か月 パフォーマンス:
+104.96%
6か月 パフォーマンス:
-55.95%
1年 パフォーマンス:
-70.70%
1日の値動き範囲:
$0.592
$0.6899
1週間の範囲:
$0.5327
$0.75
52週間の値動き範囲:
$0.25
$3.6499
Moleculin Biotech Inc Stock (MBRX) Company Profile
MBRX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MBRX
Moleculin Biotech Inc
|
0.6651 | 18.97M | 0 | -29.77M | -24.23M | -15.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Moleculin Biotech Inc Stock (MBRX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-06-09 | 再開されました | H.C. Wainwright | Buy |
| 2025-02-12 | ダウングレード | Maxim Group | Buy → Hold |
| 2022-07-18 | 再開されました | Oppenheimer | Outperform |
Moleculin Biotech Inc (MBRX) 最新ニュース
Is Moleculin Biotech Inc. a good long term investmentAchieve unparalleled market performance - jammulinksnews.com
What is Moleculin Biotech Inc. company’s growth strategyMaximize returns with expert trading insights - jammulinksnews.com
How does Moleculin Biotech Inc. compare to its industry peersInvest smarter with high-probability setups - jammulinksnews.com
Is it the right time to buy Moleculin Biotech Inc. stockUnlock real-time trading signals for gains - jammulinksnews.com
What makes Moleculin Biotech Inc. stock price move sharplyBuild a diversified portfolio for steady profits - jammulinksnews.com
What are the latest earnings results for Moleculin Biotech Inc.Capitalize on emerging trends for profits - jammulinksnews.com
What catalysts could drive Moleculin Biotech Inc. stock higher in 2025Robust financial gains - jammulinksnews.com
How volatile is Moleculin Biotech Inc. stock compared to the marketFree Stock Market Forecast Reports - jammulinksnews.com
How strong is Moleculin Biotech Inc. company’s balance sheetFree Stock Market Mentorship - jammulinksnews.com
Moleculin Biotech Releases Corporate Presentation Update - The Globe and Mail
Moleculin receives notice of intent to grant new European patent for Annamycin - MSN
Moleculin Biotech Inc. Ranks High in Smart Money TrackerROI Driven Equity Selection With Safety Emphasized - metal.it
What Caused the Sharp Drop in Moleculin Biotech (MBRX.O)? - AInvest
Moleculin Receives Notice of Intent to Grant New European Patent for Annamycin - GlobeNewswire
Will Moleculin Biotech Inc. Stock Benefit from AI and Green Energy TrendsAccurate Buy Point for Momentum Stocks Detected - metal.it
Moleculin receives European patent notice for cancer drug Annamycin By Investing.com - Investing.com Nigeria
Moleculin receives European patent notice for cancer drug Annamycin - Investing.com
Moleculin Biotech Secures European Patent for Annamycin - TipRanks
Moleculin Biotech, Inc. Receives Notice of Intent to Grant European Patent for Annamycin, Strengthening Market Position in Oncology - Quiver Quantitative
Breakthrough Cancer Drug Patent: Moleculin's Non-Cardiotoxic Treatment Gains EU Protection Until 2040 - Stock Titan
Why Did Moleculin Biotech Inc. (MBRX) Soar 10.08%? - AInvest
Statistical indicators supporting Moleculin Biotech Inc.’s strengthIntraday Trend Analysis for Fast Gains Released - metal.it
Why Did Moleculin Biotech Inc. (MBRX) Soar 11.82%? - AInvest
why MBRX is up afterhours - AInvest
Why Moleculin Biotech Inc. stock attracts strong analyst attentionValue Investing Picks With Stability Outlined - metal.it
What are analysts’ price targets for Moleculin Biotech Inc. in the next 12 monthsConsistently exceptional gains - jammulinksnews.com
When is Moleculin Biotech Inc. stock expected to show significant growthAchieve breakthrough gains with smart trades - jammulinksnews.com
whats better mbrx or pstv - AInvest
How high can Moleculin Biotech Inc. stock price go in 2025High-margin investment plays - jammulinksnews.com
Moleculin Biotech Inc. Stock Analysis and ForecastExceptional risk-adjusted gains - PrintWeekIndia
What drives Moleculin Biotech Inc. stock priceUnprecedented market success - PrintWeekIndia
What analysts say about Moleculin Biotech Inc. stockFree Risk Assessment Services - jammulinksnews.com
Moleculin Participates in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference - GlobeNewswire
Moleculin Participates in the Virtual Investor 'What’s Your Story” Summer Spotlight On-Demand Conference - The Manila Times
Exclusive: Moleculin CEO Shares Vision Behind Revolutionary Cancer Drug Pipeline in New Investor Presentation - Stock Titan
Moleculin Biotech Inc (MBRX) 財務データ
収益
当期純利益
現金流量
EPS
0.93%
0.15%
大文字化:
|
ボリューム (24 時間):